Elite Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Elite Wealth Management's XBI Position: Q3 2026 in Review
Elite Wealth Management opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q3 2026: 89,272 shares worth $14.1M. The stake represents 2.7% of the portfolio and ranks #8 among its holdings. This is a return to the name: Elite Wealth Management previously reported a position in XBI as recently as Q4 2019.
Elite Wealth Management first reported a position in XBI in Q1 2015 and has held it in 17 quarters since. 962 funds tracked by Wall St. Rank hold XBI as of Q3 2026.
- Elite Wealth Management held 89,272 shares of State Street SPDR S&P Biotech ETF worth $14.1M as of Q3 2026.
- State Street SPDR S&P Biotech ETF was a new Elite Wealth Management position in Q3 2026.
- State Street SPDR S&P Biotech ETF made up 2.7% of Elite Wealth Management's portfolio in Q3 2026, its #8 holding.
- Elite Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2015 and has held it in 17 quarters since.
- 962 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.
Based on Elite Wealth Management's 13F filing for Q3 2026, filed 3 Nov 2026.